| 
	
	 
Planer Kryo 570 ART Series Controlled Rate Freezers
 Features: •Menu driven controller, simple to programme and easy to operate •Top opening chamber lid is kept warm to prevent freezing shut at cryogenic temperatures •Multiple safety features to protect against power and PC failure •The -180°C end temperature helps sample integrity during transfers •Validation offered via controller password-controlled access on multiple user levels •Updates and alerts emailed via Wi-Fi to your PC or phone provide peace of mind •Unlimited* freezer profile storage enabling the operator to select optimum processing conditions •Copes with temporary power/system outs •Time and date stamping •Programme preview before run •Independent data storage and run •Freezes samples in vials, and straws •Horizontal or vertical freezing •Controlled warming ramps •Validation processes assisted with recording   The Kryo 570 range of controlled rate freezers is used in areas such as: •Biobanks •Cell Based Research •Biotech Areas •Human and animal IVF •Blood and Tissue Banks •Biorepositories               Regenerative Medicine
 
 Available Models: 
 
        
    
        
            | Product   Code | Description |  
            | PLGDKRYO570ART-115 | KRYO570   ART Controlled Rate Freezer System, 16 L, Medical Device, 115V, with MR7,   Each |  
            | PLGDKRYO570-M-115 | KRYO570   Controlled Rate Freezer System, 16 L, Medical Device, 115V, with MR7, Each |  
            | PLGDKRYO570-GP-115 | KRYO570   Controlled Rate Freezer System, 16 L, 115V, with MR7, Each |  
 Accessories: None available at this time. 
 Specifications:   
        
    
        
            |   | PLGDKRYO570 Series, KRYO570   Series Control Rate Freezers |  
            | Chamber   Volume | 16 L |  
            | Temperature   Range | +30°C to -180°C |  
            | Heating   Rates | 0.01°C to 10°C per minute |  
            | Cooling   Rates | -0.01°C to -50°C per minute |  
            | System   Controller | Planer MR7 Controller |  
 
 
 |  |  
      |  |  
        |  |  
|  | 
  |